Who Exports Strip from India — 612 Suppliers Behind a $196.8M Market
India's strip export market is supplied by 612 active exporters who collectively shipped $196.8M across 15,000 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 66.6% market share, followed by MANEESH PHARMACEUTICALS LIMITED and AP WAREHOUSING AND TRADING LLP. The top 5 suppliers together control 86.8% of total export value, reflecting a concentrated market structure.
Top Strip Exporters from India — Ranked by Export Value
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading strip exporter from India, holding a 66.6% share of the $196.8M market across 15,000 shipments from 612 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, MANEESH PHARMACEUTICALS LIMITED, AP WAREHOUSING AND TRADING LLP, SUN PHARMACEUTICAL INDUSTRIES LTD, SVIZERA LABS PRIVATE LIMITED — collectively control 86.8% of total export value, indicating a highly concentrated market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (66.6%), MANEESH PHARMACEUTICALS LIMITED (7.2%), AP WAREHOUSING AND TRADING LLP (6.4%), SUN PHARMACEUTICAL INDUSTRIES LTD (4.8%), SVIZERA LABS PRIVATE LIMITED (1.7%).
Top Strip Exporters from India
Ranked by export value · 612 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED KLABAX TABLETS 500MG PACK : 14S STRIP BACOLDACT FLU PLUS CAPSULE PACK:10S STRIP6 STRIPS OF 28 TABLETS EACH OF RIFAMPICI | $131.1M | 46 | 66.6% |
| 2 | MANEESH PHARMACEUTICALS LIMITED 10000 STRIPS SILDENAFIL CITRATE 100 MG6 STRIPS OF 28 TABLETS EACH OF RIFAMPICI12 STRIPS OF 28 TABLETS EACH OF RIFAMPIC | $14.1M | 6 | 7.2% |
| 3 | AP WAREHOUSING AND TRADING LLP 10000 STRIPS SILDENAFIL CITRATE 100 MG10000 STRIPS. SILDENAFIL CITRATE 100 MGLFS BULK SOYBEAN GRAIN KIT 100 STRIPPART NO: AID 040 | $12.6M | 1 | 6.4% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LTD KLABAX TABLETS 500MG PACK : 14S STRIP BACOLDACT FLU PLUS CAPSULE PACK:10S STRIP6 STRIPS OF 28 TABLETS EACH OF RIFAMPICI | $9.5M | 25 | 4.8% |
| 5 | SVIZERA LABS PRIVATE LIMITED 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICI12 STRIPS OF 28 TABLETS EACH OF RIFAMPICSTRIPOLE INJ 40 MG | $3.4M | 2 | 1.7% |
| 6 | SRS PHARMACEUTICALS PRIVATE LIMITED LUSTATIN 10 ALU-ALU BLISTER STRIP X 10S AS PER INVEVAFACT | $2.7M | 2 | 1.4% |
| 7 | ADVANOV PHARMA PRIVATE LIMITED | $2.4M | 1 | 1.2% |
| 8 | GUFIC BIOSCIENCES LIMITED 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICI12 STRIPS OF 28 TABLETS EACH OF RIFAMPICSTRIPOLE INJ 40 MG | $1.9M | 6 | 1.0% |
| 9 | ZYDUS LIFESCIENCES LIMITED MEFEX TAB 500 MG PACK: 14S STRIP BATCH:FEXOFENADINE TAB 120 MG PACK: 10S STRIPMEFEX TAB 500 MG PACK:14S STRIP BATCH:DF | $1.3M | 5 | 0.6% |
| 10 | MDC EXPORTS PRIVATE LIMITED 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICI12 STRIPS OF 28 TABLETS EACH OF RIFAMPICSTRIPOLE INJ 40 MG | $897.8K | 1 | 0.5% |
| 11 | AVANTIKA MEDEX PRIVATE LIMITED | $808.7K | 2 | 0.4% |
| 12 | ZENKO LIFE SCIENCE LLP | $743.7K | 2 | 0.4% |
| 13 | VARUN MEDIMPEX INC. 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICI12 STRIPS OF 28 TABLETS EACH OF RIFAMPIC12 STRIPS OF 28 TABLETS EACH OF RIFAMPI | $589.8K | 2 | 0.3% |
| 14 | HEXA HEALTHCARE PRIVATE LIMITED | $524.0K | 1 | 0.3% |
| 15 | CONTACARE OPHTHALMICS AND DIAGNOSTICS KLABAX TABLETS 500MG PACK : 14S STRIP BACOLDACT FLU PLUS CAPSULE PACK:10S STRIPCIFRAN CT TAB PACK: 10S STRIP BATCH: DFE | $510.3K | 18 | 0.3% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Strip exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Approved | Yes, as of April 202 | Yes | Multiple | WHO-GMP certified; FDA-approved; holds multiple ANDAs. |
| Svizera Labs Private Limited | Not Listed | Yes, as of March 202 | No | Not Listed | WHO-GMP certified; no FDA approval or ANDAs. |
| Gufic Biosciences Limited | Not Listed | Yes, as of December | No | Not Listed | WHO-GMP certified; no FDA approval or ANDAs. |
| Zydus Lifesciences Limited | Approved | Yes | Yes | Multiple | WHO-GMP certified; FDA-approved; holds multiple ANDAs. |
| Maneesh Pharmaceuticals Limited | Not Listed | Yes | No | Not Listed | WHO-GMP certified; no FDA approval or ANDAs. |
| SRS Pharmaceuticals Private Limited | Not Listed | Yes | No | Not Listed | WHO-GMP certified; no FDA approval or ANDAs. |
| Advano Pharma Private Limited | Not Listed | Yes | No | Not Listed | WHO-GMP certified; no FDA approval or ANDAs. |
| AP Warehousing and Trading LLP | Not Listed | No | No | Not Listed | No WHO-GMP certification; no FDA approval or ANDAs. |
| MDC Exports Private Limited | Not Listed | No | No | Not Listed | No WHO-GMP certification; no FDA approval or ANDAs. |
TransData Nexus reviewed the regulatory standing of 9 leading Strip exporters from India. 2 hold US FDA facility approvals, 7 maintain WHO-GMP certification, and 2 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Strip sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Pharma City of India," has established itself as a central hub for pharmaceutical research, manufacturing, and exports. The city contributes nearly 40% of the country's bulk drug production and hosts over 2,000 pharmaceutical companies. This prominence is bolstered by the presence of Genome Valley, a premier biotech cluster housing over 200 life sciences companies, including global giants like Novartis, Bayer, and Sanofi. The Telangana government's initiatives, such as the Hyderabad Pharma City project, aim to further enhance the city's infrastructure and attract additional investments in the pharmaceutical sector.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its significant contributions to pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara serving as key pharmaceutical hubs. The region is home to major companies such as Alembic Pharmaceuticals, Sun Pharmaceutical Industries, and Zydus Lifesciences. Vadodara, in particular, has a strong presence in pharmaceutical manufacturing, with numerous large-scale industries and a focus on formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being a major port city, facilitates the export of pharmaceutical products to various international markets. The region hosts several pharmaceutical companies that leverage the logistical advantages of proximity to major ports and international airports, ensuring efficient distribution channels for exports.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, primarily due to favorable tax incentives offered by the government. These incentives have attracted numerous pharmaceutical companies to set up manufacturing units in the area, contributing significantly to the production of various pharmaceutical products, including formulations like "Strip."
5Sourcing Recommendations
- Diversify Supplier Base: While Sun Pharmaceutical Industries Limited dominates the export market for "Strip" products, accounting for 66.6% of total exports, it's prudent to diversify sourcing to mitigate risks associated with over-reliance on a single supplier.
- Engage with Emerging Exporters: Consider partnerships with other significant exporters such as Maneesh Pharmaceuticals Limited and AP Warehousing and Trading LLP, which contribute 7.2% and 6.4% to the export market, respectively.
- Leverage Regional Specializations: Utilize the bulk drug manufacturing capabilities of Hyderabad for active pharmaceutical ingredients and the formulation expertise of the Ahmedabad-Vadodara corridor to optimize the supply chain.
- Monitor Export Destinations: Given that Russia, Belgium, South Africa, China, and Brazil are the top destinations for "Strip" exports, aligning sourcing strategies with market demands in these regions can enhance competitiveness.
By strategically engaging with these pharmaceutical clusters and suppliers, TransData Nexus can strengthen its supply chain resilience and capitalize on India's diverse pharmaceutical manufacturing landscape.
Common Questions — Strip Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which strip supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 2,397 recorded shipments worth $131.1M. MANEESH PHARMACEUTICALS LIMITED (34 shipments) and AP WAREHOUSING AND TRADING LLP (28 shipments) are also established high-volume exporters.
Q How many strip manufacturers are there in India?
India has 612 active strip exporters with a combined export market of $196.8M across 15,000 shipments to 170 countries. The top 5 suppliers hold 86.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for strip from India?
Average FOB unit price: $4.49 per unit, ranging from $0.00 to $3200.00. Average shipment value: $13.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 612 verified Indian exporters of Strip ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 170 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
612 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists